StockData

Exozymes Inc. (EXOZ) stock

EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$2.90−0.48 (-14.05%)

Close on Nov 20, 2026Market cap $26.96MP/E –Yield –

Exozymes revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2023 it was $70.07K.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023$70.07K–

More Exozymes figures

See a number that looks wrong?